Tian Wen Bo, Zhang Wei Sen, Jiang Chao Qiang, Liu Xiang Yi, Jin Ya Li, Lam Tai Hing, Cheng Kar Keung, Xu Lin
School of Public Health, Sun Yat-sen University, 74 Zhongshan 2nd Road, Guangzhou, Guangdong 510080, China.
Guangzhou Twelfth People's Hospital, Guangzhou 510620, China.
Lancet Reg Health West Pac. 2022 May 3;23:100460. doi: 10.1016/j.lanwpc.2022.100460. eCollection 2022 Jun.
There were no reports on the associations of aortic arch calcification (AAC) measured by chest X-ray with all-cause mortality and cardiovascular disease (CVD) in older general population. Moreover, previous studies of hemodialysis patients showed that AAC was correlated with left ventricular hypertrophy (LVH) and predicted CVD jointly. Whether the effects remained in the general population is unknown. We examined the associations of AAC with all-cause mortality and CVD in general population and the risk associated with the coexistence of AAC and LVH.
Presence and severity (grades 0-2) of AAC were measured by chest X-ray, and LVH was identified by 12-lead electrocardiogram in 27,166 Chinese aged 50+ years free of CVD from Guangzhou Biobank Cohort Study. Multivariate Cox regressions were used to examine associations of AAC and LVH with outcomes.
During an average follow-up of 14·3 years, 5,350 deaths and 4,012 CVD occurred. Compared to those without AAC at baseline, those with AAC had higher risks of all-cause mortality (HR 1·24, 95% CI 1·17-1·31) and CVD (HR 1·22, 95% CI 1·14-1·30), with dose-response relationship (P ≤ 0·001). Furthermore, those with coexistence of AAC and LVH had higher risks of all-cause mortality (HR 1·72, 95% CI 1·37-2·15) and CVD (HR 1·80, 95% CI 1·40-2·32) than those without AAC and LVH.
As chest X-ray has been performed commonly for health screening and in hospital patients when first admitted, AAC measured by chest X-ray can be further applied to assist cardiovascular risk stratification in the community and clinical settings.
The Natural Science Foundation of China (No. 81941019).
在老年普通人群中,关于通过胸部X线测量的主动脉弓钙化(AAC)与全因死亡率和心血管疾病(CVD)之间的关联尚无报道。此外,既往对血液透析患者的研究表明,AAC与左心室肥厚(LVH)相关,并共同预测CVD。这些影响在普通人群中是否依然存在尚不清楚。我们研究了普通人群中AAC与全因死亡率和CVD的关联,以及AAC和LVH共存的风险。
通过胸部X线测量AAC的存在情况和严重程度(0 - 2级),并通过12导联心电图在来自广州生物样本库队列研究的27166名年龄在50岁及以上且无CVD的中国人中识别LVH。采用多因素Cox回归分析来研究AAC和LVH与结局的关联。
在平均14.3年的随访期间,发生了5350例死亡和4012例CVD。与基线时无AAC的患者相比,有AAC的患者全因死亡率(HR 1.24,95%CI 1.17 - 1.31)和CVD风险(HR 1.22,95%CI 1.14 - 1.30)更高,且存在剂量反应关系(P≤0.001)。此外,与无AAC和LVH的患者相比,AAC和LVH共存的患者全因死亡率(HR 1.72,95%CI 1.37 - 2.15)和CVD风险(HR 1.80,95%CI 1.40 - 2.32)更高。
由于胸部X线在健康筛查和医院患者首次入院时已普遍进行,通过胸部X线测量的AAC可进一步应用于协助社区和临床环境中的心血管风险分层。
中国国家自然科学基金(编号81941019)。